21st European Gynaecological Oncology Congress of the European Society of Gynaecological Oncology
2 November|8:00 - 5 November|17:00
Leading experts in the field will present the key findings of these important studies, summarise the results, and provide a critical appraisal of the data.
The Session will focus on:
+ PARP combination studies: PRIMA/PAOLO-1/ANVANOVA2
+ First line ovarian cancer trials: VELIA/Forward1
+ Lessons learned from gynaecological cancer trials:
The results of this research will be set in context of other trials, and how the results can influence future treatment approaches of gynaecological cancers.